cutaneous lupus erythematosus |
Disease ID | 317 |
---|---|
Disease | cutaneous lupus erythematosus |
Integrated Phenotype | (Waiting for update.) |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:9) HP:0002725 | Systemic lupus erythematosus | 3 HP:0000992 | Skin photosensitivity | 2 HP:0100512 | Vitamin D deficiency | 1 HP:0007417 | Discoid lupus erythematosus | 1 HP:0003761 | Calcinosis | 1 HP:0100539 | Periorbital swelling | 1 HP:0000969 | Dropsy | 1 HP:0001581 | Recurrent skin infections | 1 HP:0002633 | Vasculitis | 1 |
Disease ID | 317 |
---|---|
Disease | cutaneous lupus erythematosus |
Manually Symptom | UMLS | Name(Total Manually Symptoms:9) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:2) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:1) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0000992 | Cutaneous photosensitivity | MP:0001202 | skin photosensitivity; |
Mapped by homologous gene(Total Items:1) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0003765 | Psoriasis | MP:0003410 | abnormal artery development;HP:0200042 | Skin ulcer |
Chemical(Total Drugs:8) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0024137 | chloroquine | D002738 | 1954/5/7 | lupus erythematosus, cutaneous | MESH:D008178 | therapeutic | 7873836 | ||
C0024137 | cinnarizine | D002936 | 298-57-7 | lupus erythematosus, cutaneous | MESH:D008178 | marker/mechanism | 9696142 | ||
C0024137 | dapsone | D003622 | 80-08-0 | lupus erythematosus, cutaneous | MESH:D008178 | therapeutic | 9451224 | ||
C0024137 | fluorouracil | D005472 | 51-21-8 | lupus erythematosus, cutaneous | MESH:D008178 | marker/mechanism | 15086387 | ||
C0024137 | pimecrolimus | C117268 | - | lupus erythematosus, cutaneous | MESH:D008178 | therapeutic | 16033622 | ||
C0024137 | rifampin | D012293 | 13292-46-1 | lupus erythematosus, cutaneous | MESH:D008178 | marker/mechanism | 11422169 | ||
C0024137 | thalidomide | D013792 | 50-35-1 | lupus erythematosus, cutaneous | MESH:D008178 | therapeutic | 11958580 | ||
C0024137 | valproic acid | D014635 | 99-66-1 | lupus erythematosus, cutaneous | MESH:D008178 | marker/mechanism | 19040509 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |